What is the role for consolidative ISRT for patients with stage III follicular lymphoma following a good response to systemic therapy?   

Advanced (stage III-IV) follicular lymphoma is not considered "curable" with either chemotherapy or immunotherapy (or the combination). A complete response may be achieved but an eventual relapse is inevitable. For patients who are asymptomatic without bulky or threatening disease, current guideline...